Lake Street Advisors Group, LLC Atara Biotherapeutics, Inc. Transaction History
Lake Street Advisors Group, LLC
- $2.05 Billion
- Q2 2024
A detailed history of Lake Street Advisors Group, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Lake Street Advisors Group, LLC holds 11,000 shares of ATRA stock, worth $93,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,000
Previous 11,000
-0.0%
Holding current value
$93,610
Previous $7,000
1228.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATRA
# of Institutions
10Shares Held
3.07MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$16 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$8.51 Million8.12% of portfolio
-
Boxer Capital, LLC San Diego, CA166KShares$1.41 Million0.08% of portfolio
-
Ifp Advisors, Inc4.5KShares$38,2950.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$38,2950.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $803M
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...